Altamira Therapeutics (CYTO) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Altamira Therapeutics (CYTO) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 29, 2024 (10:41)

Sector: Healthcare

The share price of Altamira Therapeutics Ltd. (CYTO) now

Latest session on the 28th of March for
Altamira Therapeutics Ltd. is negative
Trading Volume: 334107
Open: 2.41 /  High: 2.49 /  Low: 1.96
What analysts predict: $None
52-week High/Low: $52 / $1.61

50/200 Day Moving Average: $1.989 / $5.55

This figure corresponds to the Average Price over the previous 50/200 days. For Altamira Therapeutics stocks, the 50-day moving average is the support level today.

For Altamira Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Altamira Therapeutics Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Altamira Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Altamira Therapeutics share be worth in 2024 - 2028?

When should I take profit in Altamira Therapeutics stock? When should I record a loss on Altamira Therapeutics stock? What are analysts' forecasts for Altamira Therapeutics stock? What is the future of Altamira Therapeutics stock? We forecast Altamira Therapeutics stock performance using neural networks based on historical data on Altamira Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Altamira Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Altamira Therapeutics shares. This happens once a day.


Historical and forecast chart of Altamira Therapeutics stock

The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Altamira Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Altamira Therapeutics Ltd is committed to the development of therapeutic agents to address unmet medical needs. It is active in the treatment of RNA, allergies and viral infections, as well as in diseases of the inner ear. Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Altamira Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 31 2.00 1.95 2.04 4.37
Apr 01 2.03 1.96 2.08 5.83
Apr 02 2.01 1.95 2.05 5.08
Apr 03 1.93 1.89 2.00 5.52
Apr 04 1.97 1.87 2.04 8.75
Apr 05 2.06 1.97 2.10 6.98
Apr 06 2.08 2.04 2.17 6.19
Apr 07 2.05 2.01 2.07 3.05
Apr 08 2.07 2.03 2.11 4.04
Apr 09 2.10 2.05 2.18 6.39
Apr 10 2.07 1.99 2.10 5.99
Apr 11 2.04 1.99 2.13 6.89
Apr 12 2.08 2.00 2.17 8.24
Apr 13 2.20 2.12 2.26 6.42
Apr 14 2.28 2.22 2.34 5.43
Apr 15 2.41 2.30 2.53 9.89
Apr 16 2.39 2.33 2.49 6.84
Apr 17 2.35 2.27 2.41 5.97
Apr 18 2.24 2.18 2.33 6.73
Apr 19 2.19 2.11 2.27 7.72
Apr 20 2.15 2.08 2.24 7.75
Apr 21 2.12 2.06 2.20 6.85
Apr 22 2.23 2.19 2.30 5.21
Apr 23 2.22 2.17 2.33 7.58
Apr 24 2.18 2.08 2.21 6.30
Apr 25 2.30 2.25 2.38 5.45
Apr 26 2.36 2.27 2.39 5.56
Apr 27 2.24 2.17 2.27 4.64
Apr 28 2.23 2.13 2.27 6.58
Apr 29 2.24 2.16 2.31 6.89

Altamira Therapeutics Daily Price Targets


Altamira Therapeutics Stock Forecast 03-31-2024.

Forecast target price for 03-31-2024: $2.00.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 4.185%.
Pessimistic target level: 1.95
Optimistic target level: 2.04

Altamira Therapeutics Stock Forecast 04-01-2024.

Forecast target price for 04-01-2024: $2.03.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.504%.
Pessimistic target level: 1.96
Optimistic target level: 2.08

Altamira Therapeutics Stock Forecast 04-02-2024.

Forecast target price for 04-02-2024: $2.01.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 4.836%.
Pessimistic target level: 1.95
Optimistic target level: 2.05

Altamira Therapeutics Stock Forecast 04-03-2024.

Forecast target price for 04-03-2024: $1.93.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.231%.
Pessimistic target level: 1.89
Optimistic target level: 2.00

Altamira Therapeutics Stock Forecast 04-04-2024.

Forecast target price for 04-04-2024: $1.97.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 8.046%.
Pessimistic target level: 1.87
Optimistic target level: 2.04

Altamira Therapeutics Stock Forecast 04-05-2024.

Forecast target price for 04-05-2024: $2.06.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.527%.
Pessimistic target level: 1.97
Optimistic target level: 2.10

CYTO (CYTO) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 1.95 1.74 2.21 21.34
May. 1.93 1.69 2.21 23.87
Jun. 1.81 1.66 1.95 14.90
Jul. 1.97 1.88 2.15 12.50
Aug. 1.60 1.46 1.74 16.18
Sep. 1.82 1.66 1.96 15.61
Oct. 1.64 1.43 1.82 21.44
Nov. 1.58 1.43 1.70 15.83
Dec. 1.63 1.54 1.84 16.34

Altamira Therapeutics forecast for this year


Altamira Therapeutics Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $1.95144. Pessimistic: $1.74. Optimistic: $2.21


Altamira Therapeutics Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $1.92802. Pessimistic: $1.69. Optimistic: $2.21


Altamira Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $1.81234. Pessimistic: $1.66. Optimistic: $1.95


Altamira Therapeutics Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $1.97183. Pessimistic: $1.88. Optimistic: $2.15


Altamira Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $1.59718. Pessimistic: $1.46. Optimistic: $1.74


Altamira Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $1.82398. Pessimistic: $1.66. Optimistic: $1.96


Altamira Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $1.64158. Pessimistic: $1.43. Optimistic: $1.82


Altamira Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $1.5792. Pessimistic: $1.43. Optimistic: $1.70


Altamira Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $1.63289. Pessimistic: $1.54. Optimistic: $1.84



Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.83 1.56 1.98 20.89
Feb 1.66 1.46 1.87 22.16
Mar 1.75 1.64 1.92 14.29
Apr 1.68 1.41 1.87 24.55
May 1.73 1.58 1.88 16.02
Jun 1.81 1.74 2.07 16.23
Jul 1.80 1.55 2.04 23.68
Aug 1.93 1.65 2.10 21.55
Sep 1.92 1.83 2.10 12.82
Oct 1.83 1.65 2.03 18.92
Nov 1.76 1.64 1.85 11.41
Dec 1.94 1.81 2.15 15.86

Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 1.78 1.55 2.03 23.51
Feb 1.68 1.44 1.89 23.84
Mar 1.66 1.43 1.78 19.59
Apr 1.74 1.61 2.02 20.24
May 2.05 1.90 2.18 12.78
Jun 2.45 2.22 2.82 21.04
Jul 2.49 2.22 2.72 18.13
Aug 2.57 2.40 2.74 12.36
Sep 2.46 2.20 2.75 20.04
Oct 2.64 2.23 2.96 24.60
Nov 2.84 2.45 2.97 17.59
Dec 2.92 2.76 3.19 13.37

Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 3.00 2.72 3.32 17.90
Feb 3.26 2.77 3.74 25.96
Mar 3.34 2.84 3.62 21.59
Apr 3.51 3.05 3.98 23.46
May 4.20 3.87 4.61 15.88
Jun 4.56 4.25 5.19 18.10
Jul 3.92 3.58 4.29 16.61
Aug 3.99 3.63 4.39 17.42
Sep 4.15 3.89 4.51 13.81
Oct 3.97 3.56 4.49 20.71
Nov 4.56 4.33 5.07 14.57
Dec 5.05 4.55 5.80 21.60

Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 5.88 5.41 6.58 17.86
Feb 6.02 5.56 6.43 13.48
Mar 6.53 5.77 6.84 15.65
Apr 6.47 5.84 7.34 20.46
May 7.61 6.59 8.48 22.26
Jun 6.97 6.40 7.82 18.18
Jul 6.72 6.41 7.17 10.51
Aug 6.32 5.33 6.93 22.99
Sep 5.66 4.90 6.14 20.11
Oct 4.95 4.22 5.29 20.37
Nov 4.83 4.53 5.17 12.34
Dec 4.99 4.28 5.69 24.74

Altamira Therapeutics information and performance

Altamira Therapeutics Address

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM 11, BM

Market Capitalization: 3 087 600 $

Market capitalization of the Altamira Therapeutics Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CYTO shares in the company outstanding by the market price of one share.

EBITDA: -13 688 696 $

EBITDA of Altamira Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -445.38

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.637
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 57.29

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.307

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1837800

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Altamira Therapeutics (CYTO) stock dividend

Altamira Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 05/01/2019. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.